Lower respiratory tract infections: Prevention using vaccines

Infectious Disease Clinics of North America

Volumn 18, Issue 4, 2004, Pages 899-917

  Whitney, Cynthia G ^a   Harper, Scott A ^b  

^a Respiratory Diseases Branch   (United States)

^b Natl Ctr Infect Dis Centers D   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PNEUMOCOCCUS VACCINE; STREPTOCOCCUS VACCINE;

ABDOMINAL PAIN; AGE DISTRIBUTION; ALLERGIC ASTHMA; ANAPHYLAXIS; ARTHUS PHENOMENON; BACTEREMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE CARDIOMYOPATHY; COST EFFECTIVENESS ANALYSIS; COUGHING; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FEVER; EDEMA; ERYTHEMA; GUILLAIN BARRE SYNDROME; HEADACHE; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INFECTION RATE; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INJECTION PAIN; MALAISE; MYALGIA; NOSE CONGESTION; POSTVACCINAL ENCEPHALITIS; PREGNANT WOMAN; REVIEW; SEASONAL VARIATION; SORE THROAT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VIRUS PNEUMONIA; VIRUS SHEDDING; VOMITING;

ADULT; CHILD; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PNEUMONIA, VIRAL; RISK FACTORS;

EID: 8844257403     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2004.07.008     Document Type: Review

References (84)

1. National Center for Health Statistics Health, United States, 2003, with chartbook on trends in the health of Americans. Table 31. Leading causes of death and numbers of deaths, by sex, age, race and Hispanic origin: United States, 1980 and 2001 2003 National Center for Health Statistics Hyattsville (MD) p. 144-147
2. J.P. Nuorti, J.C. Butler, M.M. Farley, L.H. Harrison, A. McGeer, and M.S. Kolczak Cigarette smoking and invasive pneumococcal disease N Engl J Med 342 2000 681 689
3. B. Marston, H. Lipman, and R. Breiman Surveillance for legionnaires' disease: risk factors for morbidity and mortality Arch Intern Med 154 1994 2417 2422
4. W.P. Hausdorff, J. Bryant, P.R. Paradiso, and G.R. Siber Which pneumococcal serogroups cause the most invasive disease: implication for conjugate vaccine formulation and use, part 1 Clin Infect Dis 30 2000 100 121
5. K.A. Robinson, W. Baughman, G. Rothrock, N.L. Barrett, M. Pass, and C. Lexau Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era JAMA 285 2001 1729 1735
6. D.R. Feikin, A. Schuchat, M. Kolczak, N.L. Barrett, L.H. Harrison, and L. Lefkowitz Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997 Am J Public Health 90 2000 223 229
7. C.G. Whitney, M.M. Farley, J. Hadler, K.H. Harrison, N.M. Bennett, and R. Lynfield Decline in invasive pneumococcal disease following the introduction of protein-polysaccharide conjugate vaccine N Engl J Med 348 2003 1737 1746
8. B. Flannery, S. Schrag, N.M. Bennett, R. Lynfield, L.H. Harrison, and A. Reingold Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections JAMA 291 2004 2197 2203
9. M. Davidson, A.J. Parkinson, L.R. Bulkow, A. Fitzgerald, H.V. Peters, and D.J. Parks The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 - ethnic differences and opportunities for prevention J Infect Dis 170 1994 368 376
10. M.M. Cortese, M. Wolff, J. Almeido-Hill, R. Reid, J. Ketcham, and M. Santosham High incidence rates of invasive pneumococcal disease in the White Mountain Apache population Arch Intern Med 152 1992 2277 2282
11. J.P. Watt, K.L. O'Brien, A.L. Benin, C.G. Whitney, K. Robinson, and A.J. Parkinson Invasive pneumococcal disease among Navajo adults, 1989-1998 Clin Infect Dis 38 2004 496 501
12. J.P. Nuorti, J.C. Butler, L. Gelling, J.L. Kool, A.L. Reingold, and D.J. Vugia Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California Ann Intern Med 132 2000 182 190
13. L.H. Harrison, D.M. Dwyer, L. Billmann, M. Kolczak, and A. Schuchat Invasive pneumococcal infection in Baltimore, Maryland - implications for immunization policy Arch Intern Med 160 2000 89 94
14. P. Pastor, F. Medley, and T.V. Murphy Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995 Clin Infect Dis 26 1998 590 595
15. B.A. Kupronis, C.L. Richards, and C.G. Whitney Active Bacterial Core Surveillance Team. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community J Am Geriatr Soc 51 2003 1520 1525
16. R.E. Quick, C.W. Hoge, D.J. Hamilton, C.J. Whitney, M. Borges, and J.M. Kobayashi Underutilization of pneumococcal vaccine in nursing homes in Washington state: report of a serotype-specific outbreak and a survey Am J Med 94 1993 149 152
17. J.P. Nuorti, J.C. Butler, J.M. Crutcher, R. Guevara, D. Welch, and P. Holder An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents N Engl J Med 1998 1861 1868
18. A.E. Fiore, C. Inverson, and T. Messmer Outbreak of pneumonia in a long term care facility: antecedent Human Parainfluenza Virus 1 infection may predispose to bacterial pneumonia J Am Geriatr Soc 46 1998 1112 1117
19. Centers for Disease Control and Prevention Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 53 RR-6 2004 1 40
20. K.M. Neuzil, G.W. Reed, E.F.J. Mitchel, and M.R. Griffin Influenza-associated morbidity and mortality in young and middle-aged women JAMA 281 1999 901 907
21. M. Susser, and A. Adelstein An introduction to the Work of William Farr Am J Epidemiol 101 1975 469 476
22. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, N. Cox, and L.J. Anderson Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 2003 179 186
23. K. Stevens The pathophysiology of influenza pneumonia in 1918 Perspect Biol Med 25 1981 115 125
24. R. Austrian Life with the pneumococcus: notes from the bedside, laboratory, and library 1985 University of Pennsylvania Press Philadelphia
25. E.D. Kilbourne, and N.H. Arden Inactivated influenza vaccines S.A. Plotkin W.A. Orenstein Vaccines 3rd edition 1999 W. B. Saunders & Company Philadelphia 531 552
26. Centers for Disease Control and Prevention Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 46 No. RR-8 1997 1 24
27. Centers for Disease Control and Prevention Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices MMWR 52 2003 739 740
28. W.F. Carman, A.G. Elder, L.A. Wallace, K. McAulay, A. Walker, and G.D. Murray Effects of influenza vaccination of healthcare workers on mortality of elderly people in long term care: a randomized controlled trial Lancet 355 2000 93 97
29. J. Potter, D.J. Stott, M.A. Roberts, A.G. Elder, B. O'Donnell, and P.V. Knight Influenza vaccination of health-care workers in long-term care hospitals reduces the mortality of elderly patients N Engl J Med 348 1997 1322 1332
30. J.C. Butler, R.F. Breiman, J.F. Campbell, H.B. Lipman, C.V. Broome, and R.R. Facklam Polysaccharide pneumococcal vaccine efficacy: an evaluation of current recommendations JAMA 270 1993 1826 1831
31. R.V. Sims, W.C. Steinmann, J.H. McConville, L.R. King, W.C. Zwick, and J.S. Schwartz The clinical effectiveness of pneumococcal vaccine in the elderly Ann Intern Med 108 1988 653 657
32. E.D. Shapiro, A.T. Berg, R. Austrian, D. Schroeder, V. Parcells, and A. Margolis The protective efficacy of polyvalent pneumococcal polysaccharide vaccine N Engl J Med 325 1991 1453 1460
33. B.M. Farr, B.L. Johnston, D.K. Cobb, M.J. Fisch, T.P. Germanson, and K.A. Adal Preventing pneumococcal bacteremia in patients at risk: results of a matched case-control study Arch Intern Med 155 1995 2336 2340
34. L.A. Jackson, K.M. Neuzil, O. Yu, P. Benson, W.E. Barlow, and A.L. Adams Effectiveness of pneumococcal polysaccharide vaccine in older adults N Engl J Med 348 2003 1747 1755
35. I. Koivula, M. Stén, M. Leinonen, and P.H. Mäkelä Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial Am J Med 103 1997 281 290
36. M.S. Simberkoff, A.P. Cross, M. Al-Ibrahim, A.L. Baltch, P.J. Geiseler, and J. Nadler Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study N Engl J Med 315 1986 1318 1327
37. Å. Örtqvist, J. Hedlund, L.Å. Burman, E. Elbel, M. Hofer, and M. Leinonen Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-age and elderly people Lancet 351 1998 399 403
38. A.L. Benin, K.L. O'Brien, J.P. Watt, R. Reid, E.R. Zell, and S. Katz Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults J Infect Dis 188 2003 81 89
39. N. French, J. Nakiyingi, L.M. Carpenter, E. Lugada, C. Watera, and K. Moi 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial Lancet 355 2000 2106 2111
40. M.S. Dworkin, J.W. Ward, D.L. Hanson, J.L. Jones, and J.E. Kaplan Adult and Adolescent Spectrum of HIV Disease Project. Pneumococcal disease among HIV-infected persons: incidence, risk factors, and impact of vaccination Clin Infect Dis 32 2001 794 800
41. R.F. Breiman, D.W. Keller, M. Phelan, D.H. Sniadack, D.S. Stephens, and D. Rimland Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients Arch Intern Med 160 2000 2633 2638
42. J.E. Sisk, A.J. Moskowitz, W. Whang, J.D. Lin, D.S. Fedson, and A.M. McBean Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people JAMA 278 1997 1333 1339
43. J.E. Sisk, W. Whang, J.C. Butler, V.-P. Sneller, and C.G. Whitney Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race Ann Intern Med 138 2003 960 968
44. A. Palache Influenza vaccines: a reappraisal of their use Drugs 54 1997 841 856
45. K.L. Nichol, K.L. Margolis, J. Wuorenma, and T. Von Sternberg The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community N Engl J Med 331 1994 778 784
46. J.P. Mullooly, M.D. Bennett, M.C. Hornbrook, W.H. Barker, W.W. Williams, and P.A. Patriarca Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization Ann Intern Med 121 1994 947 952
47. K.L. Nichol, J. Wuorenma, and T. von Sternberg Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens Arch Intern Med 158 1998 1769 1776
48. P.A. Patriarca, J.A. Weber, R.A. Parker, W.N. Hall, A.P. Kendal, and D.J. Bregman Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic JAMA 253 1985 1136 1139
49. N.H. Arden, P.A. Patriarca, and A.P. Kendal Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes A.P. Kendal P.A. Patriarca Options for the control of influenza 1986 Alan R. Liss, Inc. New York 155 168
50. R.B. Belshe, W.C. Gruber, P.M. Mendelman, I. Cho, K. Reisinger, and S.L. Block Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine J Pediatr 136 2000 168 175
51. R.B. Belshe, P.M. Mendelman, J. Treanor, J. King, W.C. Gruber, and P. Piedra Efficacy of live-attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children N Engl J Med 338 1998 1405 1412
52. K.L. Nichol, P.M. Mendelman, K.P. Mallon, L.A. Jackson, G.J. Gorse, and R.B. Belshe Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized, controlled trial JAMA 281 1999 137 144
53. J.J. Treanor, K. Kotloff, R.F. Betts, R. Belshe, F. Newman, and D. Iacuzio Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and V viruses Vaccine 18 2000 899 906
54. K.L. Nichol, J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly N Engl J Med 348 14 2003 1322 1332
55. M. Loeb, A. McGeer, M. McArthur, S. Walter, and A.E. Simor Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities Arch Intern Med 159 1999 2058 2064
56. P.O. Honkanen, T. Keistinen, L. Miettinen, E. Herva, U. Sankilampi, and E. Laara Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older Vaccine 17 1999 2493 2500
57. K.L. Nichol, L. Baken, J. Wuorenma, and A. Nelson The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease Arch Intern Med 159 1999 2437 2442
58. M.J. Fine, M.A. Smith, and C.A. Carson Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials Arch Intern Med 154 1994 2666 2677
59. L.A. Jackson, P. Benson, V.-P. Sneller, J.C. Butler, R.S. Thompson, and R.T. Chen Safety of revaccination with pneumococcal polysaccharide vaccine JAMA 281 3 1999 243 248
60. A.H. Ropper The Guillain-Barre syndrome N Engl J Med 326 1992 1130 1136
61. T.J. Safranek, D.N. Lawrence, L.T. Kurland, D.H. Culver, W.C. Wiederholt, and N.S. Hayner Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group Am J Epidemiol 133 1991 940 951
62. L.B. Schonberger, D.J. Bregman, J.Z. Sullivan-Bolyai, R.A. Keenlyside, D.W. Ziegler, and H.F. Retailliau Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977 Am J Epidemiol 110 1979 105 123
63. T. Lasky, G.J. Terracciano, L. Magder, C.L. Koski, M. Ballesteros, and D. Nash The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines N Engl J Med 339 1998 1797 1802
64. Chen R, Kent J, Rhodes P, Simon P, Schonberger L. Investigation of a possible association between influenza vaccination and Guillain-Barré syndrome in the United States, 1990-1991 [abstract 040]. In: Post Marketing Surveillance. Rockville (MD): US Food and Drug Administration; 1992.
65. E.S. Hurwitz, L.B. Schonberger, D.B. Nelson, and R.C. Holman Guillain-Barré syndrome and the 1978-1979 influenza vaccine N Engl J Med 304 1981 1557 1561
66. J.E. Kaplan, P. Katona, E.S. Hurwitz, and L.B. Schonberger Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981 JAMA 248 1982 698 700
67. US Department of Health and Human Services. Healthy People 2010, Volume I: Objectives for Improving Health (Part A: Focus Areas 1-14). Available at: http://www.healthypeople.gov. Accessed on August 16, 2004.
68. Centers for Disease Control and Prevention Public health and aging: influenza vaccination coverage among adults aged ≥ 50 years and pneumococcal vaccination coverage among adults aged ≥ 65 years - United States, 2002 MMWR 52 2003 987 992
69. Centers for Disease Control and Prevention Reasons reported by medicare beneficiaries for not receiving influenza and pneumococcal vaccinations-United States, 1996 MMWR 48 1999 556 890
70. K.R. Ehresmann, A. Ramesh, K. Como-Sabetti, D.C. Peterson, C.G. Whitney, and K.A. Moore Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul metropolitan area Prev Med 32 2001 409 415
71. K.L. Nichol, R. MacDonald, and M. Hauge Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults J Gen Intern Med 11 1996 673 677
72. K. Nichol Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults Am J Med 105 1998 385 392
73. T.W. Gyorkos, T.N. Tannenbaum, M. Abrahamowicz, L. Bedard, J. Carsley, and E.D. Franco Evaluation of the effectiveness of immunization delivery methods Can J Pub Health 85 Suppl 1 1994 S14 S30
74. D.C. Rhew, P.A. Glassman, and M.B. Goetz Improving pneumococcal vaccine rates: nurse protocols versus clinical reminders J Gen Intern Med 14 1999 351 356
75. Centers for Disease Control and Prevention Notice to readers: facilitating influenza and pneumococcal vaccination through standing orders programs MMWR 52 2003 68 69
76. Centers for Disease Control and Prevention Use of standing orders programs to increase adult vaccination rates MMWR 49 RR01 2000 15 26
77. P.A. Briss, L.E. Rodewald, A.R. Hinman, A.M. Shefer, R.A. Strikas, and R.R. Bernier Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults Am J Prev Med 18 1S 2000 97 140
78. Task Force on Community Preventive Services Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults Am J Prev Med 18 1S 2000 92 96
79. C. Whitney, W. Schaffner, and J. Butler Rethinking recommendations for use of pneumococcal vaccines in adults Clin Infect Dis 33 2001 662 675
80. S. Black, H. Shinefield, B. Fireman, E. Lewis, P. Ray, and J.R. Hansen Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group Pediatr Infect Dis J 19 2000 187 195
81. J. Eskola, T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, and E. Herva Efficacy of a pneumococcal conjugate vaccine against acute otitis media N Engl J Med 344 2001 403 409
82. B. Abraham-Van Parijs Review of pneumococcal conjugate vaccine in adults: implications on clinical development Vaccine 22 2004 1362 1371
83. Centers for Disease Control and Prevention Using live, attenuated influenza vaccine for prevention and control of influenza; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 52 RR13 2003 1 8
84. Centers for Disease Control and Prevention Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 52 RR08 2003 1 36